Healthcare Triangle, Inc. (HCTI)
NASDAQ: HCTI · Real-Time Price · USD
2.180
-0.050 (-2.24%)
At close: Apr 28, 2026, 4:00 PM EDT
2.190
+0.010 (0.46%)
Pre-market: Apr 29, 2026, 4:45 AM EDT
Healthcare Triangle Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 13.89 | 11.7 | 33.2 | 45.89 | 35.27 | |
| Revenue Growth (YoY) | 18.77% | -64.77% | -27.64% | 30.10% | 12.54% | |
| Cost of Revenue | 12 | 8.81 | 26.43 | 34.59 | 24.75 | |
| Gross Profit | 1.89 | 2.89 | 6.78 | 11.3 | 10.52 | |
| Selling, General & Admin | 10.42 | 6.15 | 10.4 | 12.17 | 9.2 | |
| Research & Development | 0.54 | 0.43 | 0.8 | 8.14 | 5.26 | |
| Operating Expenses | 11.68 | 7.64 | 12.76 | 23.25 | 15.88 | |
| Operating Income | -9.79 | -4.75 | -5.99 | -11.96 | -5.36 | |
| Interest Expense | -0.57 | -1.21 | -0.97 | -0.21 | -0.57 | |
| Currency Exchange Gain (Loss) | -0.02 | - | - | - | - | |
| Other Non Operating Income (Expenses) | 0.86 | 0.01 | 0.01 | - | - | |
| EBT Excluding Unusual Items | -9.52 | -5.96 | -6.94 | -12.17 | -5.93 | |
| Asset Writedown | 0.04 | - | -1.71 | -4.37 | - | |
| Other Unusual Items | - | - | - | 2.68 | - | |
| Pretax Income | -9.48 | -5.96 | -8.65 | -13.85 | -5.93 | |
| Income Tax Expense | - | 0.01 | 0.04 | 0.51 | 0.02 | |
| Net Income | -9.48 | -5.97 | -8.69 | -14.36 | -5.95 | |
| Net Income to Common | -9.48 | -5.97 | -8.69 | -14.36 | -5.95 | |
| Shares Outstanding (Basic) | 0 | - | - | - | - | |
| Shares Outstanding (Diluted) | 0 | - | - | - | - | |
| EPS (Basic) | -153.15 | - | - | - | - | |
| EPS (Diluted) | -153.15 | - | - | - | - | |
| Free Cash Flow | -16.53 | -1.08 | -2.16 | -5.39 | -7.19 | |
| Free Cash Flow Per Share | -267.14 | - | - | - | - | |
| Gross Margin | 13.61% | 24.71% | 20.41% | 24.62% | 29.83% | |
| Operating Margin | -70.47% | -40.62% | -18.02% | -26.06% | -15.19% | |
| Profit Margin | -68.22% | -51.03% | -26.16% | -31.29% | -16.87% | |
| Free Cash Flow Margin | -118.99% | -9.24% | -6.51% | -11.75% | -20.39% | |
| EBITDA | -9.08 | -3.86 | -4.42 | -9.02 | -3.94 | |
| EBITDA Margin | -65.40% | -33.02% | -13.31% | -19.65% | -11.16% | |
| D&A For EBITDA | 0.71 | 0.89 | 1.57 | 2.94 | 1.42 | |
| EBIT | -9.79 | -4.75 | -5.99 | -11.96 | -5.36 | |
| EBIT Margin | -70.47% | -40.62% | -18.02% | -26.06% | -15.19% | |
| Advertising Expenses | 1.7 | 0.61 | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.